✦ LIBER ✦

Neoadjuvant therapy for locally advanced cancer

✍ Scribed by Stephen F. Sener

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 32 KB
Volume: 101
Category: Article
ISSN: 0022-4790
DOI: 10.1002/jso.21475

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk of cerebral metastases and neurolog

Risk of cerebral metastases and neurological death after pathological complete response to neoadjuvant therapy for locally advanced nonsmall-cell lung cancer : Clinical implications for the subsequent management of the brain

✍ Allen M. Chen; Thierry M. Jahan; David M. Jablons; Joaquin Garcia; David A. Lars 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB

## Abstract ## BACKGROUND. The incidence and pattern of brain metastases was analyzed among patients who achieved a pathological complete response (pCR) after neoadjuvant chemotherapy or chemoradiotherapy for locally advanced nonsmall‐cell lung cancer (NSCLC). ## METHODS. Between 1990 and 2004,

Neoadjuvant therapy of locally advanced

Neoadjuvant therapy of locally advanced gastric cancer

✍ James J. Mezhir; Laura H. Tang; Daniel G. Coit 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB

## Abstract Treatment of gastric cancer has evolved with the advent of randomized trials demonstrating chemotherapeutic agents with efficacy in advanced disease. Level I evidence supports delivering chemotherapy in the neoadjuvant setting; the data shows improvement in progression‐free and overall

Neoadjuvant chemotherapy in locally adva

Neoadjuvant chemotherapy in locally advanced breast cancer

✍ Singh, Gurpreet; Singh, Deepinder P.; Gupta, Devender; Muralikrishna, Bhavaraju 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB 👁 2 views

Thirty-eight patients with locally advanced breast cancer (Stage HI) were treated over a 3-year period. All patients initially received two cycles of CMF (cyclophosphamide, 100 mg/m2 p.0. dl-14; methotrexate 40mg/m2 intravenously (iv), d l and d8., 5 Fluorouracil 500 mg/m2 iv d l and d8). They were

Neoadjuvant strategies for the treatment

Neoadjuvant strategies for the treatment of locally advanced esophageal cancer

✍ John R. Hyngstrom; Mitchell C. Posner 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

## Abstract Patients with locally advanced esophageal carcinoma have consistently poor survival following surgery with associated high systemic and local‐regional failure rates. Neoadjuvant therapeutic strategies have been employed in an attempt to improve outcome with variable success. Randomized

Neoadjuvant docetaxel treatment for loca

Neoadjuvant docetaxel treatment for locally advanced prostate cancer : A clinicopathologic study

✍ Cristina Magi-Galluzzi; Ming Zhou; Alwyn M. Reuther; Robert Dreicer; Eric A. Kle 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 250 KB

## Abstract ## BACKGROUND. The objective of the current study was to determine the histologic and molecular changes that occurred in patients with high‐risk, localized prostate cancer (PCa) after neoadjuvant docetaxel chemotherapy. ## METHODS. Patients who had locally advanced PCa (serum preoper

Neoadjuvant therapy followed by prostate

Neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancer

✍ Guru Sonpavde; Kim N. Chi; Thomas Powles; Christopher J. Sweeney; Noah Hahn; Tho 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

## Abstract The results of this assessment of the literature indicated that neoadjuvant therapy followed by prostatectomy may improve long‐term outcomes for patients with high‐risk localized disease. In addition, this approach provides a paradigm for evaluating the activity and mechanism of action